Related Experiment Video
Updated: Apr 6, 2026

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
Lack of the scavenger receptor CD36 alters microglial phenotypes after neonatal stroke
Fan Li1,2, Joel Faustino1, Moon-Sook Woo1
1Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Abstract:
The stage of brain development at the time of stroke has a major impact on the pathophysiological mechanisms of ischemic damage, including the neuroinflammatory response. Microglial cells have been shown to contribute to acute and subchronic injury in adult stroke models, whereas in neonatal rodents we showed that microglial cells serve as endogenous neuroprotectants early following transient middle cerebral artery occlusion, limiting neuroinflammation and injury. In the neonate, microglial depletion or lack of the scavenger receptor CD36 exacerbates injury. In this study we asked if lack of CD36 affects microglial phenotypes after neonatal stroke. Using RT-PCR we characterized the patterns of gene expression in microglia isolated from injured regions following acute transient middle cerebral artery occlusion in postnatal day 10 mice and showed that expression of several pro-inflammatory genes, including Toll-like receptors, remains largely unaffected in activated microglia in injured regions. Using multiple biochemical assays we demonstrated that lack of CD36 alters several functions of microglia in acutely injured neonatal brain: it further enhances accumulation of the chemokine MCP-1, affects the number of CD11b(+) /CD45(+) cells, along with protein expression of its co-receptor, Toll-like receptor 2, but does not affect accumulation of superoxide in microglia or the cytokines TNFα and IL-1β in injured regions.
Insights
In neonatal stroke, the scavenger receptor CD36 is crucial for microglial neuroprotection. Lack of CD36 exacerbates brain injury by altering microglial function and chemokine accumulation.
Area of Science:
- Neuroscience
- Immunology
- Developmental Biology
Background:
- Brain development stage influences stroke pathophysiology and neuroinflammation.
- Microglia act as neuroprotectants in neonatal stroke, unlike in adult models.
- Scavenger receptor CD36 deficiency exacerbates neonatal stroke injury.
Purpose of the Study:
- To investigate the impact of CD36 deficiency on microglial phenotypes in neonatal stroke.
- To understand how CD36 absence affects microglial responses to ischemic injury in the developing brain.
Main Methods:
- Neonatal mice (postnatal day 10) underwent transient middle cerebral artery occlusion.
- Microglia were isolated from injured brain regions for analysis.
- RT-PCR and biochemical assays were used to assess gene expression and microglial function.
Main Results:
- Pro-inflammatory gene expression in activated microglia was largely unaffected by CD36 deficiency.
- CD36 absence enhanced MCP-1 accumulation and altered CD11b+/CD45+ cell counts.
- CD36 deficiency did not affect superoxide accumulation or TNFα and IL-1β levels.
Conclusions:
- CD36 plays a critical role in modulating microglial function post-neonatal stroke.
- While not affecting all inflammatory markers, CD36 deficiency alters specific microglial responses, impacting injury outcomes.

